Comparisons of test statistics arising from marginal analyses of multivariate survival data

Lifetime Data Analysis

Volumn 10, Issue 4, 2004, Pages 389-405

  Li, Qian H ^a   Lagakos, Stephen W ^b  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Directional tests; Marginal model; Multivariate survival data; Omnibus test; Recurring events

Indexed keywords

AIDS RELATED COMPLEX; ARTICLE; COMPARATIVE STUDY; EPIDEMIOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MORTALITY; MULTIVARIATE ANALYSIS; RECURRENT DISEASE; REGRESSION ANALYSIS; SAMPLE SIZE; SENSITIVITY AND SPECIFICITY; STATISTICAL MODEL; SURVIVAL;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; EPIDEMIOLOGIC RESEARCH DESIGN; HIV INFECTIONS; HUMANS; MODELS, STATISTICAL; MULTIVARIATE ANALYSIS; RECURRENCE; REGRESSION ANALYSIS; SAMPLE SIZE; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS;

EID: 14844293467     PISSN: 13807870     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10985-004-4774-x     Document Type: Conference Paper

References (16)

1. P.K. Andersen R.D. Gill 1981 Cox's regression model for counting processes: A large sample study The Annals of Statistics 10 1100 1120
2. J. Cai R.L. Prentice 1995 Estimating equations for hazard ratio parameters based on correlated failure time data Biometrika 82 151 164
3. R. J. Cook, J. F. Lawless, and C. Nadeau, "Robust tests for treatment comparisons based on recurrent event responses", Technical Report vol. 40 1995.
4. D.R. Cox 1972 Regression models and life tables Journal of Royal Statististical Society B 34 187 220
5. R. Dolin D.A. Amato M.A. Fischl 1995 Zidovudine compared with didanosine in patients with advanced HIV type 1 infection and little or no previous experience with zidovudine Archives of Internal Medicine 155 9 961 974
6. W.A. Hauser S.S. Rich. J. R.-J. Lee J.F. Annegers V.E. Anderson 1998 Risk of recurrent seizures after two unprovoked seizures New England Journal of Medicine 338 429 434
7. M. Hughes 1997 Power considerations for clinical trials using multivariate time to event data Statistical in Medicine 16 865 882
8. J. Kahn S.W. Lagakos D.D. Richman A. Cross 1992 A controlled trial comparing continued zidovudine with didanosine in human immunodeficiency virus infection New England Journal of Medicine 327 581 587
9. Q. H. Li, The Relationship between Directional and Omnibus Tests for a Vector Parameter, Doctoral Thesis, Department of Biostatistics, Harvard University, 1997.
10. K.Y. Liang S.G. Self Y.C. Chang 1993 Modeling marginal hazards in multivariate failure time data Journal of Royal Statistical Society B 55 441 453
11. D.Y. Lin 1994 Cox regression of multivariate failure time data: The marginal approach Statistical in Medicine 13 2233 2247
12. J.S. Lin L.J. Wei 1992 Linear regression analysis for multivariate failure time observations JASA 87 1091 1097
13. R.L. Prentice B.J. Williams A.V. Peterson 1981 On the regression analysis of multivariate failure time Data Biometrika 68 373 379
14. D. Richman J. Grimes S. Lagakos 1990 Effect of stage of disease and drug dose on zidovudine susceptibilities of isolates of human immunodeficiency virus Journal of Acquired Immune Deficiency Syndromes 3 743 746
15. L.J. Wei D.Y. Lin L. Weissfeld 1989 Regression analysis of multivariate incomplete failure time data by modeling marginal distributions JASA 84 1065 1073
16. Y. Yang Z. Ying 2001 Marginal proportional hazards models for multipleevent-time data Biometrika 88 581 586